|
T-2 Toxin
|
D23.946.587.933.950.500 |
|
|
Shivering
|
G07.410.421.778.500 |
|
|
Thermogenesis
|
G07.410.421.778 |
|
|
Supranuclear Palsy, Progressive
|
C10.574.945.500 |
|
|
Molecularly Imprinted Polymers
|
D25.720.517 |
|
|
Health Literacy
|
L01.143.450.500 |
|
|
Information Literacy
|
L01.143.450 |
|
|
Encephalomyelitis, Eastern Equine
|
C10.228.140.430.520.750.450.200 |
|
|
Durapatite
|
D01.695.625.675.650.075.025.300.150 |
|
|
Hydroxyapatites
|
D01.695.625.675.650.075.025.300 |
|
|
Lyme Disease
|
C01.920.930.513 |
|
|
Reimbursement, Incentive
|
N03.219.521.710.305.380 |
|
|
Rickets, Hypophosphatemic
|
C18.654.521.500.133.770.734.875 |
|
|
Rickets
|
C18.654.521.500.133.770.734 |
|
|
Venlafaxine Hydrochloride
|
D10.289.510.500.901 |
|
|
Lissamine Green Dyes
|
D02.675.276.475 |
|
|
Bradykinin
|
D23.529.812.169 |
|
|
Bifidobacterium breve
|
B03.510.460.400.400.049.100.375 |
|
|
Emergency Service, Hospital
|
N04.452.442.452.422.336 |
|
|
Binding Sites
|
G02.111.570.120 |
|
